| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050263449 |
| P356 | DOI | 10.1007/S10096-013-1819-7 |
| P698 | PubMed publication ID | 23354675 |
| P2093 | author name string | T Gastinne | |
| G Potel | |||
| E Batard | |||
| E Montassier | |||
| M F de La Cochetière | |||
| P2860 | cites work | Bacterial infection profiles in lung cancer patients with febrile neutropenia | Q31021400 |
| Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study | Q33341476 | ||
| The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis | Q33594436 | ||
| Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria | Q33756519 | ||
| Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia | Q33756523 | ||
| Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures | Q33983331 | ||
| Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation | Q34095684 | ||
| Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome | Q34106854 | ||
| Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course | Q36004592 | ||
| Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection | Q36094979 | ||
| Clinical implications of chemotherapy-induced diarrhea in patients with cancer | Q36138678 | ||
| Febrile neutropenia in haematological malignancies. | Q36414770 | ||
| Clinical and economic impact of common multidrug-resistant gram-negative bacilli | Q36482801 | ||
| The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients | Q36895914 | ||
| Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy | Q37624439 | ||
| Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients | Q37946180 | ||
| Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia | Q38467189 | ||
| Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy | Q38474339 | ||
| Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study | Q39785102 | ||
| Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. | Q39910428 | ||
| Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. | Q40284635 | ||
| P. aeruginosa bloodstream infections among hematological patients: an old or new question? | Q40295711 | ||
| Bacteraemia in febrile neutropenic cancer patients | Q40442274 | ||
| Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. | Q40452033 | ||
| Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens | Q40496949 | ||
| Management of fever in neutropenic patients with different risks of complications | Q40530034 | ||
| Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis | Q40663090 | ||
| Bacterial isolates in neutropenic febrile patients | Q40752257 | ||
| Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies | Q42558452 | ||
| Escherichia coli resistance to quinolones at a comprehensive cancer center | Q43062604 | ||
| Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern | Q43071379 | ||
| Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms | Q43201542 | ||
| Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan | Q43279810 | ||
| Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora | Q43511486 | ||
| Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea | Q43593616 | ||
| Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). | Q43945108 | ||
| Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study | Q43984868 | ||
| Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States | Q44035214 | ||
| Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States | Q44417864 | ||
| Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies | Q46094551 | ||
| Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients | Q46847070 | ||
| Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit | Q46867182 | ||
| Clinical characteristics and prognostic factors of Acinetobacter nosocomialis bacteraemia in patients with solid tumours. | Q48659269 | ||
| Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. | Q51599708 | ||
| Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. | Q51617424 | ||
| Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. | Q54373146 | ||
| Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. | Q54376284 | ||
| Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients | Q62200379 | ||
| Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation | Q73445980 | ||
| High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey | Q73733536 | ||
| Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk | Q74579181 | ||
| Susceptibility surveillance among gram-negative bacilli at a cancer center | Q78209053 | ||
| Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies | Q83419434 | ||
| Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India | Q83451289 | ||
| Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients | Q83958584 | ||
| High incidence of methicillin-resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin Hospital | Q84516931 | ||
| P433 | issue | 7 | |
| P921 | main subject | patient | Q181600 |
| antibiotic resistance | Q380775 | ||
| epidemiology | Q133805 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 841-850 | |
| P577 | publication date | 2013-01-25 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance | |
| P478 | volume | 32 |
| Q43548235 | 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. |
| Q48136538 | A fresh look at polymicrobial bloodstream infection in cancer patients. |
| Q89766009 | Activity of Cefiderocol and Comparators against Isolates from Cancer Patients |
| Q47654366 | Admissions for antibiotic-resistant infections in cancer patients during first year of cancer diagnosis: a cross-sectional study. |
| Q38212258 | Antibiotic resistance in cancer patients. |
| Q33760545 | Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China |
| Q89746228 | Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study |
| Q33690666 | Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study |
| Q26863733 | Bacterial effectors and their functions in the ubiquitin-proteasome system: insight from the modes of substrate recognition |
| Q59796495 | Bacterial profile, antibiotic resistance pattern and associated factors among cancer patients at University of Gondar Hospital, Northwest Ethiopia |
| Q89287985 | Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era |
| Q40500618 | Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. |
| Q40755934 | Bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal single-center study |
| Q35858106 | Bloodstream infections in patients with malignancies: Implications for antibiotic treatment in a Ghanaian tertiary setting |
| Q38703440 | Bloodstream infections in patients with solid tumors. |
| Q36247827 | Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center |
| Q93114987 | Carrier prevalence and risk factors for colonisation of multiresistant bacteria in Danish emergency departments: a cross-sectional survey |
| Q89578268 | Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences |
| Q42233832 | Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology |
| Q50119378 | Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients. |
| Q35683371 | Chemotherapy-driven dysbiosis in the intestinal microbiome. |
| Q44998054 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers |
| Q40852571 | Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies |
| Q58736943 | Cross sectional study of multiresistant bacteria in Danish emergency departments: prevalence, patterns and risk factors for colonization (AB-RED project) |
| Q45828036 | Does a learned journal require regular re-vamping? |
| Q24201136 | Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer |
| Q38747206 | Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. |
| Q49821085 | Epidemiology and Outcomes of Bloodstream Infections in Patients With Solid Tumors in a Central American Population at Mexico Hospital, San Jose, Costa Rica. |
| Q55339985 | Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature. |
| Q42208310 | Epidemiology and outcome of bacteraemia in neutropenic patients in a single institution from 1991-2012. |
| Q40992066 | Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. |
| Q39515812 | Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients |
| Q28543554 | Factors associated with hospital length of stay among cancer patients with febrile neutropenia |
| Q36048603 | Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients |
| Q40252885 | In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients |
| Q42215430 | In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients |
| Q92783689 | Infections Due to Multidrug-Resistant Bacteria in Oncological Patients: Insights from a Five-Year Epidemiological and Clinical Analysis |
| Q42224671 | Invasive bacterial and fungal infections in paediatric patients with cancer: incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009-2011. |
| Q34999884 | Invasive gram-positive bacterial infection in cancer patients |
| Q37363377 | Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities. |
| Q51735719 | Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge. |
| Q38188881 | Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. |
| Q34678894 | Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. |
| Q38207933 | Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). |
| Q38940456 | Managing the oncologic patient with suspected pneumonia in the intensive care unit |
| Q64236569 | Microbial and Antibiotic Susceptibility Profile among Isolates of Clinical Samples of Cancer Patients Admitted in the Intensive Care Unit at Regional Tertiary Care Cancer Center: A Retrospective Observational Study |
| Q57073881 | Microbial spectrum and drug-resistance profile of isolates causing bloodstream infections in febrile cancer patients at a referral hospital in Addis Ababa, Ethiopia |
| Q47196467 | Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients |
| Q52721675 | Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small cell lung cancer. |
| Q38749061 | Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions |
| Q38848903 | Oritavancin activity against Staphylococcus aureus causing invasive infections in U.S. and European hospitals: a 5-year international surveillance program |
| Q37440871 | Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer |
| Q38611490 | Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study |
| Q36001287 | Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection |
| Q39444336 | Prevalence and risk factors of Gram-negative bacilli causing blood stream infection in patients with malignancy |
| Q55368723 | Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations. |
| Q38550985 | Question 2: what are the risk factors for antibiotic resistant Gram-negative bacteraemia in children with cancer? |
| Q33892651 | Rare bacterial isolates causing bloodstream infections in Ethiopian patients with cancer |
| Q55496879 | Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. |
| Q47283908 | Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications |
| Q35209399 | Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications |
| Q38538705 | Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms |
| Q38131442 | The current spectrum of infection in cancer patients with chemotherapy related neutropenia. |
| Q34474989 | The dormant blood microbiome in chronic, inflammatory diseases |
| Q40706134 | The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013. |
| Q38875315 | The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies |
| Q38171538 | The prevention and management of infections due to multidrug resistant organisms in haematology patients |
| Q36007787 | The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. |
| Q35208666 | The surface rhamnopolysaccharide epa of Enterococcus faecalis is a key determinant of intestinal colonization. |
| Q35077317 | Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correla |
Search more.